These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 4780926)

  • 1. Indicators of mumps immunity and the effect of intradermal antigen and mumps vaccine on antibody level.
    Bart KJ; Nankervis GA; Gold E
    Am J Epidemiol; 1973 Jul; 98(1):39-42. PubMed ID: 4780926
    [No Abstract]   [Full Text] [Related]  

  • 2. Correlation between the potency of mumps virus skin test antigen and cutaneous delayed hypersensitivity.
    Dufour FD; Arce MA; St Geme JW
    J Pediatr; 1972 Oct; 81(4):742-6. PubMed ID: 5074351
    [No Abstract]   [Full Text] [Related]  

  • 3. [Modification of the mumps hemagglutination-inhibition antibody determination method and inoculation test of live mumps vaccine (Hoshino strain)].
    Kakihana J
    Kansenshogaku Zasshi; 1976 Apr; 50(4):145-52. PubMed ID: 824381
    [No Abstract]   [Full Text] [Related]  

  • 4. Studies on live mumps virus vaccine. 3. Evaluation of newly developed live mumps virus vaccine.
    Yamanishi K; Takahashi M; Kurimura T; Ueda S; Minekawa Y
    Biken J; 1970 Sep; 13(3):157-61. PubMed ID: 4992054
    [No Abstract]   [Full Text] [Related]  

  • 5. Differences in antibodies to the surface components of mumps virus after immunization with formalin-inactivated and live vaccines.
    Norrby E; Penttinen K
    J Infect Dis; 1978 Nov; 138(5):672-6. PubMed ID: 712121
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of mumps vaccine given after exposure to mumps, with special reference to the exposed adult.
    Meyer MB; Stifler WC; Joseph JM
    Pediatrics; 1966 Feb; 37(2):304-15. PubMed ID: 5902092
    [No Abstract]   [Full Text] [Related]  

  • 7. Topical unresponsiveness of depigmented areas.
    Kahn G
    Arch Dermatol; 1970 Jun; 101(6):662-3. PubMed ID: 5424481
    [No Abstract]   [Full Text] [Related]  

  • 8. [Mumps-antibody formation in guinea pigs following a single virus application. Evaluation of live mumps-virus vaccine].
    Gladthe H; Abel C
    J Hyg Epidemiol Microbiol Immunol; 1972; 16(2):202-7. PubMed ID: 5064723
    [No Abstract]   [Full Text] [Related]  

  • 9. Clinical studies with virulent and attenuated mumps viruses.
    Ennis FA; Douglas RD; Hopps HE; Meyer HM; Brown ER; Hobbins TE; Biehusen FC
    Am J Epidemiol; 1969 Feb; 89(2):176-83. PubMed ID: 5765957
    [No Abstract]   [Full Text] [Related]  

  • 10. Persistence of immunity following monovalent and combined live measles, mumps, and rubella virus vaccines.
    Weibel RE; Buynak EB; Stokes J; Hilleman MR
    Pediatrics; 1973 Mar; 51(3):467-75. PubMed ID: 4707864
    [No Abstract]   [Full Text] [Related]  

  • 11. Combined live measles-mumps virus vaccine.
    Weibel RE; Villarejos VM; Hernández G; Stokes J; Buynak EB; Hilleman MR
    Arch Dis Child; 1973 Jul; 48(7):532-6. PubMed ID: 4719108
    [No Abstract]   [Full Text] [Related]  

  • 12. Evaluation of cellular immunity to mumps in vaccinated individuals with or without circulating antibodies up to 16 years after their last vaccination.
    Vandermeulen C; Clement F; Roelants M; Van Damme P; Hoppenbrouwers K; Leroux-Roels G
    J Infect Dis; 2009 May; 199(10):1457-60. PubMed ID: 19320590
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Functional state of specific immunity in children and teenagers vaccinated against mumps].
    Otrashevskaia EV; Bukin EK; Krasil'nikov IV; Ignat'ev GM
    Vopr Virusol; 2010; 55(4):20-5. PubMed ID: 20886708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Mumps virus-specific antibody titers from pre-vaccine era sera: comparison of the plaque reduction neutralization assay and enzyme immunoassays.
    Mauldin J; Carbone K; Hsu H; Yolken R; Rubin S
    J Clin Microbiol; 2005 Sep; 43(9):4847-51. PubMed ID: 16145156
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell-mediated immune response to mumps virus infection in man.
    Chiba Y; Dzierba JL; Morag A; Ogra PL
    J Immunol; 1976 Jan; 116(1):12-5. PubMed ID: 1245735
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Enzyme-linked immunosorbent assay of mumps antibody for evaluation of immune status before and after vaccination.
    Kuno-Sakai H; Iwasaki H; Kimura M
    J Infect Dis; 1984 May; 149(5):813. PubMed ID: 6726005
    [No Abstract]   [Full Text] [Related]  

  • 17. Immunologic significance of the mumps virus skin test in infants, children and adults.
    Geme JW; Yamauchi T; Eisenklam EJ; Noren GR; Aase JM; Jurmain RB; Henn RM; Gabel MC; Hollister AW; Paumier R
    Am J Epidemiol; 1975 Mar; 101(3):253-63. PubMed ID: 163575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Investigation of mumps vaccine failures in Minsk, Belarus, 2001-2003.
    Atrasheuskaya AV; Blatun EM; Kulak MV; Atrasheuskaya A; Karpov IA; Rubin S; Ignatyev GM
    Vaccine; 2007 Jun; 25(24):4651-8. PubMed ID: 17498853
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Delayed skin reactivity to mumps antigen].
    Orriols R; Morell F; de Gracia X; Sanz R; Muñiz R; Joan-Miquel L
    Med Clin (Barc); 1983 Jun; 81(1):14-6. PubMed ID: 6888053
    [No Abstract]   [Full Text] [Related]  

  • 20. Screening for mumps immunity with the microtiter solid-phase radioimmunoassay.
    Hernandez R; Just M; Bürgin-Wolff A
    Infection; 1976; 4(3):121-4. PubMed ID: 977135
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.